Mesenchymal precursor cells didn't boost wean rates from heart assist devices
CHICAGO – An attempt to employ stem cells to rescue patients from left ventricular assist devices (LVAD) failed to provide benefit to the patients in an National Institutes of Health-supported clinical trial, researchers reported here.